TNFRSF1B and myasthenia gravis: Specifically, TNFR2 ablation in MG induced an early-onset disease with increased leukocyte infiltration and T cell activation and demyelination, whereas its depletion in monocytes/MФ suppressed EAE, impaired T cell activation, and reduced demyelination (Gao et al., 2017).